Compare Greenlane Holdings (GNLN) With Other Cannabis Stocks

Head-to-head stock comparisons across price, valuation, financials, and growth metrics

Company

Greenlane Holdings (GNLN)

Price

$49.51

Change

-3.31%

Market Cap

$790.0M

Sector

Ancillary

Ancillary Sector Peers

All Ancillary cannabis companies sorted by market capitalization. Click any ticker to see a detailed head-to-head comparison.

TickerNamePriceChange %MCap
SMGScotts Miracle-Gro$63.45-1.45%$3.68B
TPBTurning Point Brands$76.86+0.49%$1.49B
AGFYAgrify Corp$47.12+4.71%$94.2M
GRWGGrowGeneration$1.290.00%$81.1M
FORAForian Inc$2.150.00%$67.1M
GRAMFTPCO Holding (The Parent Company)$0.16-12.99%$45.7M
MAPSWM Technology (Weedmaps)$0.39-11.03%$42.0M
HYFMHydrofarm Holdings$1.00+5.25%$4.7M
FNNZFFinCanna Capital$0.00+38.10%$545.2K

Top Matchups by Market Cap

Companies closest to Greenlane Holdings in market capitalization — the most meaningful head-to-head comparisons.

TLRYLP

Tilray Brands

MCap: $729.3M

$6.05+0.80%
Compare
GLASFMSO

Glass House Brands

MCap: $608.3M

$7.50-2.72%
Compare
MSOSETF

AdvisorShares Pure US Cannabis ETF

MCap: $973.9M

$4.86-0.21%
Compare
CRONLP

Cronos Group

MCap: $990.3M

$2.58-0.19%
Compare
VRNOFMSO

Verano Holdings

MCap: $457.6M

$1.26-8.70%
Compare

Cross-Sector Comparisons

Top cannabis companies outside the Ancillary sector. Compare across different business models and market segments.

JAZZBiotech

Jazz Pharmaceuticals

MCap: $12.19B

$199.90-0.97%
Compare
CURLFMSO

Curaleaf Holdings

MCap: $1.80B

$2.36+2.83%
Compare
IIPRREIT

Innovative Industrial Properties

MCap: $1.56B

$53.68-0.39%
Compare
GTBIFMSO

Green Thumb Industries

MCap: $1.54B

$6.56+7.01%
Compare
TCNNFMSO

Trulieve Cannabis

MCap: $1.22B

$6.40+4.92%
Compare

Comparing GNLN in the Cannabis Market

Greenlane Holdings (GNLN) is a Ancillary-sector cannabis company trading at $49.51 per share with a market capitalization of $790.0M. Among its Ancillary peers, GNLN ranks #3 by market cap, with trailing twelve-month revenue of $1.20B and a gross margin of 49.8%. The stock has moved -3.31% in the current session, trading on the NASDAQ exchange.

When comparing GNLN against other cannabis stocks, investors should consider key financial metrics including price-to-sales ratio (8.0x), revenue growth (+28.60% YoY), and balance sheet strength (cash of $309.3M vs. debt of $617.4M). The comparison tables above allow you to evaluate Greenlane Holdings relative to 9 sector peers and leading companies across all cannabis sub-sectors, helping you identify which stocks offer better value, stronger growth, or more favorable risk profiles.

Frequently Asked Questions

How does GNLN compare to other Ancillary stocks?+
Greenlane Holdings has a market cap of $790.0M, placing it among 10 companies in the Ancillary sector. Its price-to-sales ratio is 8.0x and its gross margin is 49.8%. Use the table above to compare these metrics against every Ancillary peer.
What is GNLN's biggest competitor?+
By market capitalization, the closest comparable company is Tilray Brands (TLRY) with a market cap of $729.3M. Click the compare link to view a full head-to-head analysis.
Is GNLN overvalued compared to its peers?+
Greenlane Holdings trades at a P/S ratio of 8.0x. Compare this to sector peers in the table above to determine relative valuation. A lower P/S may indicate relative value, while a higher P/S may reflect growth expectations.
Which cannabis stock has better margins than GNLN?+
Greenlane Holdings has a gross margin of 49.8%. Among its Ancillary peers, 4 companies report higher gross margins. See the Sector Peers table for a full ranking.
Can I compare GNLN to stocks in other cannabis sectors?+
Yes. The Cross-Sector Comparisons section above features top companies from sectors outside Ancillary. You can click any company to see a full side-by-side comparison with GNLN covering price, valuation, financials, and growth metrics.

All GNLN Comparisons

Every available head-to-head comparison for Greenlane Holdings.

Related Pages

Disclaimer: The comparison data on this page is for informational purposes only and does not constitute financial advice, investment recommendations, or an endorsement of any security. Cannabis stocks are highly volatile and subject to unique regulatory risks. Always conduct your own research and consult a licensed financial advisor before making investment decisions.Cannabismarketcap does not guarantee the accuracy or completeness of any data presented.